Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
CollPlant Biotechnologies Ltd. CLGN
$6.80
+$0.14 (2.10%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
75829928.00000000
-
week52high
13.97
-
week52low
4.27
-
Revenue
299000
-
P/E TTM
-4439
-
Beta
0.64948000
-
EPS
-1.56000000
-
Last Dividend
0.00000000
-
Next Earnings Date
24 мая 2023 г. в 12:30
Описание компании
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 09 февр 2021 г. |
| HC Wainwright & Co. | Buy | 25 ноя 2020 г. | |
| H.C. Wainwright | Buy | 25 ноя 2020 г. | |
| HC Wainwright & Co. | Buy | 28 мая 2020 г. | |
| H.C. Wainwright | Buy | 03 апр 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
CollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript
Seeking Alpha
29 мар 2023 г. в 12:28
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2022 Earnings Conference Call March 29, 2023 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - Chief Executive Officer Eran Rotem - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Swayampakula Ramakanth - H.C.
CollPlant: Expanding End-Market Opportunities
Seeking Alpha
12 февр 2023 г. в 06:31
Possesses only plant-based collagen product with multiple end-market opportunities. AbbVie relationship alone justifies the current valuation.
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy
PRNewsWire
19 сент 2022 г. в 07:00
REHOVOT, Israel , Sept. 19, 2022 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the Company will make a presentation on "Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications" at the International Conference on Biofabrication on September 28 th.
New Strong Sell Stocks for April 22nd
Zacks Investment Research
22 апр 2022 г. в 10:32
BBBY, CLGN, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2022